1312422-72-2Relevant academic research and scientific papers
CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR
-
, (2011/07/08)
The present invention provides crystalline forms of a mesylate salt of the compound 5-chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide and pharmaceutical compositions and methods thereof.
METHODS OF PREPARING FACTOR XA INHIBITORS AND SALTS THEREOF
-
, (2011/07/06)
The present invention provides for methods of preparing compounds of Formula I or a salt of the compound or a hydrate of the compound or salt thereof that are factor Xa inhibitors. Specifically the present invention provides a method of preparing the comp
SALTS AND CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR
-
, (2011/08/03)
The present invention provides salts and crystalline forms of the compound 5-chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide, and pharmaceutical compositions and method of use thereof.
